Cite
HARVARD Citation
Dos Santos, M. et al. (2017). Impact of targeted therapies in metastatic renal cell carcinoma on patient-reported outcomes: Methodology of clinical trials and clinical benefit. Cancer treatment reviews. pp. 53-60. [Online].